Provided by Tiger Trade Technology Pte. Ltd.

Relay Therapeutics

7.49
+0.09001.22%
Post-market: 7.41-0.0800-1.07%18:15 EST
Volume:1.52M
Turnover:11.32M
Market Cap:1.30B
PE:-4.28
High:7.61
Open:7.40
Low:7.23
Close:7.40
52wk High:8.36
52wk Low:1.78
Shares:173.32M
Float Shares:102.63M
Volume Ratio:0.82
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7494
EPS(LYR):-2.3638
ROE:-41.14%
ROA:-25.37%
PB:2.14
PE(LYR):-3.17

Loading ...

Relay Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 26

Relay Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $14 From $16

THOMSON REUTERS
·
Aug 26

Stock Track | Relay Therapeutics Plummets 8.60% Despite Beating Q2 Estimates as Raymond James Slashes Target Price

Stock Track
·
Aug 08

Relay Therapeutics Q2 EPS $(0.41) Beats $(0.48) Estimate, Sales $677.000K Beat $54.545K Estimate

Benzinga
·
Aug 08

Relay Therapeutics Q2 Operating Income USD -76.847 Million

THOMSON REUTERS
·
Aug 08

Relay Therapeutics Q2 Revenue USD 677 Thousand

THOMSON REUTERS
·
Aug 08

Relay Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
Aug 06

Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025

GlobeNewswire
·
Aug 01

Peter Rahmer, Officer, Reports Disposal of Common Shares of Relay Therapeutics Inc

Reuters
·
Jul 31

CFO Thomas Catinazzo Reports Disposal of Common Shares in Relay Therapeutics Inc

Reuters
·
Jul 31

Donald A. Bergstrom, President of R&D at Relay Therapeutics Inc., Reports Disposal of Common Shares

Reuters
·
Jul 31

Relay Therapeutics CEO Sanjiv Patel Reports Disposal of Common Shares

Reuters
·
Jul 11

Press Release: Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

Dow Jones
·
Jun 12

Relay Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 07

Relay Therapeutics Signs Lease for New Kendall Square Office, Reducing Rent by $16 Million

Reuters
·
Jun 05

Relay Therapeutics Announces Launch of Phase 3 ReDiscover-2 Study for RLY-2608 in Breast Cancer Treatment

Reuters
·
Jun 02

Relay Therapeutics Inc. to Participate in Jefferies and Goldman Sachs Global Healthcare Conferences

Reuters
·
May 30